JP2021514365A5 - - Google Patents
Info
- Publication number
- JP2021514365A5 JP2021514365A5 JP2020543919A JP2020543919A JP2021514365A5 JP 2021514365 A5 JP2021514365 A5 JP 2021514365A5 JP 2020543919 A JP2020543919 A JP 2020543919A JP 2020543919 A JP2020543919 A JP 2020543919A JP 2021514365 A5 JP2021514365 A5 JP 2021514365A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- activity inhibitor
- ire1α
- endoribonuclease activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305169 | 2018-02-16 | ||
| EP18305169.7 | 2018-02-16 | ||
| PCT/EP2019/053807 WO2019158689A1 (en) | 2018-02-16 | 2019-02-15 | Methods and compositions for treating liver diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021514365A JP2021514365A (ja) | 2021-06-10 |
| JP2021514365A5 true JP2021514365A5 (https=) | 2022-02-18 |
Family
ID=61283136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543919A Pending JP2021514365A (ja) | 2018-02-16 | 2019-02-15 | 肝疾患を処置するための方法及び組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20210085643A1 (https=) |
| EP (1) | EP3752135A1 (https=) |
| JP (1) | JP2021514365A (https=) |
| WO (1) | WO2019158689A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250082663A1 (en) * | 2021-06-15 | 2025-03-13 | Yale University | Compounds and methods for treating or preventing autosomal dominant polycystic kidney disease (adpkd), autosomal dominant polycystic liver disease (adpld) and/or autosomal recessive polycystic kidney disease (arpkd) |
| CN113647359A (zh) * | 2021-08-15 | 2021-11-16 | 芜湖职业技术学院 | 注射衣霉素诱导急性肝损伤小鼠模型的构建方法 |
| KR102718502B1 (ko) * | 2021-10-13 | 2024-10-16 | 단국대학교 천안캠퍼스 산학협력단 | 쌍별귀뚜라미 가수분해물을 유효성분으로 함유하는 비알코올성 지방간 질환 예방 또는 개선용 식품 조성물 및 이의 제조방법 |
| CN114712514B (zh) * | 2022-03-03 | 2023-03-31 | 浙江大学 | 用于局部和全身性减脂的纳米制剂及其应用 |
| CN116549442A (zh) * | 2023-06-08 | 2023-08-08 | 复旦大学 | Stf-083010在制备防治主动脉夹层药物中的应用 |
| CN119185312B (zh) * | 2024-10-11 | 2026-04-21 | 浙江大学 | 盐酸胺苯吖啶在制备防治纤维化疾病的药物中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103079558B (zh) * | 2010-04-05 | 2025-09-12 | 上海复星医药产业发展有限公司 | IRE-1α抑制剂 |
| WO2016004254A1 (en) * | 2014-07-01 | 2016-01-07 | The Regents Of The University Of California | Combined modulation of ire1 |
| WO2020019107A1 (en) * | 2018-07-23 | 2020-01-30 | Fosun Orinove Pharmatech, Inc. | IRE1α INHIBITOR IN COMBINATION WITH CANCER THERAPEUTIC AGENT FOR CANCER TREATMENT |
-
2019
- 2019-02-15 EP EP19705960.3A patent/EP3752135A1/en not_active Withdrawn
- 2019-02-15 JP JP2020543919A patent/JP2021514365A/ja active Pending
- 2019-02-15 WO PCT/EP2019/053807 patent/WO2019158689A1/en not_active Ceased
- 2019-02-15 US US16/970,031 patent/US20210085643A1/en not_active Abandoned
-
2023
- 2023-06-02 US US18/328,042 patent/US20240024281A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514365A5 (https=) | ||
| LUC00053I2 (fr) | Anticorps diriges contre cd38 pour le traitement du myelome multiple | |
| SA521422068B1 (ar) | عوامل مساعدة لـ glp-1r واستخداماتها | |
| JP2007051159A5 (https=) | ||
| JP2021530451A5 (https=) | ||
| JP2016512425A5 (https=) | ||
| PE20212108A1 (es) | Compuestos dirigidos a brm y metodos de uso asociados | |
| NO20083793L (no) | Antistoffer mot amyloid-beta peptid | |
| PE20140963A1 (es) | Compuestos de isoindolina para el tratamiento de cancer | |
| RU2018106914A (ru) | 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция | |
| CN113412260A (zh) | 己酮糖激酶抑制剂及其用途 | |
| JP2024028337A5 (https=) | ||
| BRPI0413490A (pt) | novos compostos | |
| JP2019059781A5 (https=) | ||
| CR9721A (es) | Compuestos de carbamato para utilizar en el tratamiento de desordenes neurodegenerativos | |
| BR112018015238A2 (pt) | conjugado de anticorpo, anticorpo, kit, composição farmacêutica, e, métodos para tratar ou prevenir uma doença ou condição e para diagnosticar uma doença ou condição | |
| JP2017113019A5 (https=) | ||
| JP2008526765A5 (https=) | ||
| NO20075815L (no) | Formuleringer og metoder for behandling av amyloidose | |
| JP2018503685A5 (https=) | ||
| JP2021535175A5 (https=) | ||
| TN2009000144A1 (fr) | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer | |
| CO6361848A2 (es) | Composición para controlar enfermedades vegetales y metodo para controlar enfermedades vegetales | |
| CN109311893A (zh) | 含有取代环戊基的吡咯并嘧啶化合物 | |
| BRPI0407368A (pt) | tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas. |